Paul Mcdade Email & Phone Number

I am fortunate that I have had the opportunity to bring medicines, devices and supplements to market that have had a huge impact on QOL and longevity for patients. Launching Rejeneril-A, a unique dietary supplement developed to combat HIV-related fatigue to introducing the most successful biologic to date -- remicade -- for the treatment of rheumatoid arthritis as well as psoriasis and Crohn's disease. In the area of transplantation I helped Roche to introduce both Zenepax and Cellcept, which combined have prevented the rejection of transplanted organs in hundreds of thousands of patients worlwide. Also gratifying was my work on Xeloda for breast cancer that I helped to bring through the regulatory process, which also has gone on to help millions of people worldwide. Working equally in the US, Europe, Asia and South America I am familiar with the critical challenges marketers face in an increasingly competitive world, especially as the US market slows and other markets must shoulder a larger burden to drive bottom line results. Compounding this challenge, is the “chasm” that has emerged between large agencies and their clients. Senior pr executives are being pulled in too many directions just when their clients need more of their time to meet the new communications reality. As the author of many articles and presentations that have identified important trends, issues and opportunities, I am keenly aware that the divide between clients and large agencies is growing larger and the pace is quickening. Starting a healthcare focused agency that will never grow to a size that will prevent us from providing senior level involvement on every account and assignment is one of the most effective operating models to ensure clients meet their obectives. At CMPR we strive to meet clients most pressing needs – we do this by being nimble, requiring a senior counselor be involved at all times -- and possibly the most important – we do it cost effectively!Specialties: pharma, biotech, C-suite visibility, US and EMEA regulatory expertise, clinical trials, crisis/issues management, media training/coaching, corp and product branding and marketing, mergers and acquisitions communications. OTC and neutracueticals, devices and technology platforms/advances are also areas of core competency